Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vlad

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Biomedicines|November 26, 2022
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of SchizophreniaCristian Petrescu, Ioana R Papacocea, Crisanda Vilciu, et al.
Cancer Immunology, Immunotherapy : CII|August 20, 2009
A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancerAnda M Vlad, Raluca A Budiu, Diana E Lenzner, et al.
Acta Endocrinologica (Bucharest, Romania : 2005)|June 1, 2019
NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTSA Sima, I Sporea, R Timar, et al.
Oncogene|December 7, 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profilesShannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancerSwati Suryawanshi, Xin Huang, Esther Elishaev, et al.
Science Advances|November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibitionSandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Cancer and Clinical Oncology|June 13, 2017
Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse ModelRaluca A Budiu, Anda M Vlad, Linda Nazario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
Biomarkers in Medicine|July 26, 2018
Inflammatory biomarker in adipose stem cells of women with endometrial cancerFaina Linkov, Sharon L Goughnour, Shalkar Adambekov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancerSwati Suryawanshi, Anda M Vlad, Hui-Min Lin, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Biomedicines|November 26, 2022
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of SchizophreniaCristian Petrescu, Ioana R Papacocea, Crisanda Vilciu, et al.
Cancer Immunology, Immunotherapy : CII|August 20, 2009
A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancerAnda M Vlad, Raluca A Budiu, Diana E Lenzner, et al.
Acta Endocrinologica (Bucharest, Romania : 2005)|June 1, 2019
NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTSA Sima, I Sporea, R Timar, et al.
Oncogene|December 7, 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profilesShannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancerSwati Suryawanshi, Xin Huang, Esther Elishaev, et al.
Science Advances|November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibitionSandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Cancer and Clinical Oncology|June 13, 2017
Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse ModelRaluca A Budiu, Anda M Vlad, Linda Nazario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
Biomarkers in Medicine|July 26, 2018
Inflammatory biomarker in adipose stem cells of women with endometrial cancerFaina Linkov, Sharon L Goughnour, Shalkar Adambekov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancerSwati Suryawanshi, Anda M Vlad, Hui-Min Lin, et al.
Pageof 10